Botulinum Toxin A/B/D/E (BTX A/B/D/E) antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-Botulinum Toxin A/B/D/E (BTX A/B/D/E) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Mycotoxins diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-159-1 | 1. BSA-Botulinum Toxin A/B/D/E
(BTX A/B/D/E) 2. Anti-Botulinum Toxin A/B/D/E (BTX A/B/D/E) mouse monoclonal antibody | $2709.00 |
GMP-SMT-159-2 | 1. OVA-Botulinum Toxin A/B/D/E
(BTX A/B/D/E) 2. Anti-Botulinum Toxin A/B/D/E (BTX A/B/D/E) mouse monoclonal antibody | $2709.00 |
GMP-SMT-159-3 | 1. BSA-Botulinum Toxin A/B/D/E
(BTX A/B/D/E) 2. Anti-Botulinum Toxin A/B/D/E (BTX A/B/D/E) human monoclonal antibody | $2709.00 |
GMP-SMT-159-4 | 1. OVA-Botulinum Toxin A/B/D/E
(BTX A/B/D/E) 2. Anti-Botulinum Toxin A/B/D/E (BTX A/B/D/E) human monoclonal antibody | $2709.00 |
GMP-SMT-159-Ag-1 | BSA-Botulinum Toxin A/B/D/E (BTX A/B/D/E) | $756.00 |
GMP-SMT-159-Ag-2 | OVA-Botulinum Toxin A/B/D/E (BTX A/B/D/E) | $756.00 |
GMP-SMT-159-Ab-1 | Anti-Botulinum Toxin A/B/D/E (BTX A/B/D/E) mouse monoclonal antibody | $1953.00 |
GMP-SMT-159-Ab-2 | Anti-Botulinum Toxin A/B/D/E (BTX A/B/D/E) human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-Botulinum Toxin A/B/D/E (BTX A/B/D/E)
Cat No. | GMP-SMT-159-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Botulinum Toxin A/B/D/E (BTX A/B/D/E) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Botulinum Toxin A/B/D/E (BTX A/B/D/E) had been validated with our anti-Hapten antibody Anti-Botulinum Toxin A/B/D/E (BTX A/B/D/E) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-Botulinum Toxin A/B/D/E (BTX A/B/D/E)
Cat No. | GMP-SMT-159-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-Botulinum Toxin A/B/D/E (BTX A/B/D/E) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Botulinum Toxin A/B/D/E (BTX A/B/D/E) had been validated with our anti-Hapten antibody Anti-Botulinum Toxin A/B/D/E (BTX A/B/D/E) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Botulinum Toxin A/B/D/E (BTX A/B/D/E) mouse monoclonal antibody
Cat No. | GMP-SMT-159-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.6-2 |
Products description | The anti-Hapten antibody against hapten Botulinum Toxin A/B/D/E (BTX A/B/D/E) had been validated with our hapten hapten-carrier conjugates BSA-Botulinum Toxin A/B/D/E (BTX A/B/D/E) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Botulinum Toxin A/B/D/E (BTX A/B/D/E) human monoclonal antibody
Cat No. | GMP-SMT-159-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.6-2 |
Products description | The anti-Hapten antibody against hapten Botulinum Toxin A/B/D/E (BTX A/B/D/E) had been validated with our hapten hapten-carrier conjugates BSA-Botulinum Toxin A/B/D/E (BTX A/B/D/E) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Biomarker Information
1. Botulinum Toxin A/B/D/E (BTX A/B/D/E) and its Relevance in Toxin Classification:
1.1 Nature and Origin (1):
Botulinum Toxin A/B/D/E (BTX A/B/D/E) represents a group of potent neurotoxic proteins produced by the anaerobic bacterium Clostridium botulinum. While these toxins are not classified as mycotoxins, their biological properties and significance in toxin classification make them subjects of compelling scientific interest.
1.2 Toxin Classification Context (2):
Mycotoxins, typically originating from molds, have long been the focus of toxin research. However, Botulinum Toxins A/B/D/E serve as exemplars of the broader spectrum of toxins that can undermine food safety and human health. Their inclusion highlights the diverse array of toxins capable of contaminating food sources.
1.3 Food Contamination and Health Implications (3):
Although not mycotoxins, Botulinum Toxins A/B/D/E can infiltrate various food products, creating a formidable health risk. These toxins precipitate botulism, an acute neuromuscular illness characterized by paralysis and, in severe cases, life-threatening respiratory failure. Consequently, the presence of BTX A/B/D/E in food emphasizes the pressing need for precise toxin detection and management.
2. Significance of Measuring Botulinum Toxin A/B/D/E (BTX A/B/D/E):
2.1 Safeguarding Public Health (4):
The measurement of Botulinum Toxin A/B/D/E assumes paramount importance for several compelling reasons:
Public Health Protection: The extreme toxicity of BTX A/B/D/E necessitates timely detection to prevent botulism outbreaks, thereby safeguarding public health. Quick and accurate measurements are imperative to avert the severe consequences associated with toxin exposure.
Regulatory Compliance (5):
To ensure food safety, regulatory agencies worldwide have imposed stringent limits on Botulinum Toxin A/B/D/E levels in food products. Strict adherence to these regulations is mandatory to prevent legal ramifications and maintain consumer confidence in food products.
Quality Assurance (6):
The assurance of toxin-free food products is pivotal for preserving product quality and consumer trust. Rigorous monitoring and precise measurement are essential to uphold product integrity and ensure that contamination is promptly addressed.
Biopharmaceutical Research (7):
Companies specializing in anti-small molecules antibodies and competitive antigens can harness the precision of BTX A/B/D/E measurements to develop targeted antibodies and antigens for diagnostic and therapeutic purposes. This research significantly contributes to the evolution of toxin detection methodologies and the development of innovative solutions for toxin-related health risks.
Scientific Advancements (8):
The detailed study of Botulinum Toxin A/B/D/E, including precise measurements, facilitates scientific advancements in toxin research. This extends beyond food safety and biopharmaceuticals to encompass a broader understanding of the mechanisms and implications of toxins in various fields.
In summary, while Botulinum Toxin A/B/D/E differs from mycotoxins, its measurement holds critical importance due to its extreme toxicity, regulatory compliance demands, quality assurance considerations, and its relevance in advancing toxin detection methods and therapeutic interventions. Accurate detection and effective toxin management are pivotal for upholding food safety standards, protecting public health, driving scientific research, and advancing biopharmaceutical applications. The comprehensive understanding and precise measurement of these toxins are indispensable for addressing toxin-related challenges on multiple fronts.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.